Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
This field safety notice serves to inform customers of a change in primer reactivity: 1) primer b-110a in the listed b high res unitrays does not amplify b*1335 b*1535 and b*9541 alleles and 2) primer b54-o4a in the listed b22 unitrays does not amplify b*390601 and b*3928 alleles.